Like most websites we use cookies. This is to ensure that we give you the best experience possible.
Continuing to use www.cabi.org means you agree to our use of cookies. If you would like to, you can learn more about the cookies we use.
Veterinary information to support practice, based on evidence and continuing education
Log out of VetMed Resource and My CABI.
This will :
Access to over 2.2 million abstracts, over 145,000 full text documents, and news articles, book chapters and disease datasheets
Advanced Bibliographic Search
VetMed Resource smart searches are based on commonly researched topics, and your own requests
Sign up to receive our Veterinary & Animal Sciences e-newsletter, book alerts and offers direct to your inbox.
3 results found
Results per page:
The potential of a recombinant Schistosoma bovis 28-kDa glutathione S-transferase (rSb28GST) to protect cattle against Fasciola hepatica was tested in a vaccination trial. Thirty-two calves were randomly divided into four groups of eight animals. Calves of the three vaccine groups received two...
The potential of a recombinant Schistosoma bovis-derived glutathione S-transferase [glutathione transferase] (rSb28GST) to protect calves against S. mattheei infection was tested in Zambia. All animals were challenged 2 weeks after the second inoculation with either 0.250 mg rSb28GST in adjuvants...
Sera from calves vaccinated with the recombinant Schistosoma bovis-derived 28-kDa glutathione S-transferase (28GST) and subsequently naturally or experimentally exposed to S. mattheei were studied for their content of specific immunoglobulin G (IgG) and IgA antibodies to recombinant S. bovis 28GST, ...